Julie Hambleton Spring Works Therapeutics, Inc. (SWTX) insider trading activity
Julie Hambleton is Director of SpringWorks Therapeutics, Inc.. Currently has a direct ownership of 4,095 shares of SWTX, which is worth approximately $221,703. The most recent transaction as insider was on Feb 10, 2025, when has been sold 13,774 shares (Common Stock) at a price of $53.01 per share, resulting in proceeds of $730,159. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
4.1K
0%
3M change
11.9%
12M change
Total Value Held
$221,703
Julie Hambleton Transaction History
Also insider at
JH
Julie Hambleton
Director
Stamford,, CT